Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
826.41
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Huge News for Eli Lilly Stock Investors!
May 18, 2025
Via
The Motley Fool
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?
May 18, 2025
Via
The Motley Fool
Got $1,000 to Invest? Buy This Top Vanguard ETF and Never Look Back.
May 17, 2025
Via
The Motley Fool
Topics
ETFs
MarketBeat Week in Review – 05/12 - 05/16
May 17, 2025
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Government
Eli Lilly Pulls Ahead Of Novo In Obesity Drug Gold Rush As New Players Crowd In
May 16, 2025
Eli Lilly has steadily gained market share against Novo's Wegovy which finds itself catching up.
Via
Talk Markets
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
May 16, 2025
Via
Benzinga
Discover which S&P500 stocks are making waves on Friday.
May 16, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via
Chartmill
9 Health Care Stocks With Whale Alerts In Today's Session
May 16, 2025
Via
Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
May 16, 2025
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.
Via
Benzinga
Topics
Government
Stocks Fight For Fifth Day Of Gains, Dollar Rebounds As Inflation Fears Go Haywire: What's Driving Markets Friday?
May 16, 2025
Wall Street fought for a fifth consecutive day of gains on Friday, with major indexes edging slightly higher by midday in New York as investors continued to digest the week's significant trade...
Via
Benzinga
Topics
Economy
Explore the top gainers and losers within the S&P500 index in today's session.
May 16, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
May 16, 2025
Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.
Via
Investor's Business Daily
Wall Street Expects This Obesity Drug Stock to Skyrocket 35% Over the Next 12 Months
May 16, 2025
Via
The Motley Fool
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
May 15, 2025
Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential deal value above $1.3 billion.
Via
Benzinga
Is It Time to Buy the Dip in Novo Nordisk Stock?
May 15, 2025
Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing
Via
MarketBeat
Topics
Government
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
May 15, 2025
Via
The Motley Fool
Topics
Economy
Government
2 Stocks That Plummeted During President Trump's First 100 Days in Office, and Where They Could Be Headed
May 15, 2025
The stock market experienced quite a bit of volatility during President Donald Trump's first 100 days in office.
Via
The Motley Fool
Topics
Artificial Intelligence
Fraud
Government
3 Market-Beating Stocks with Promising Prospects
May 15, 2025
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...
Via
StockStory
LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price Pressures
May 14, 2025
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion. The company expects the full...
Via
StockStory
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
May 14, 2025
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
May 14, 2025
Via
Benzinga
Got $500? 1 Billionaire-Approved Vanguard Index Fund to Buy and Hold Forever
May 14, 2025
Investing in index funds can be an incredibly lucrative way to build wealth.
Via
The Motley Fool
Topics
ETFs
Economy
Why Weight-Loss Developer Stocks Tumbled on Tuesday
May 13, 2025
Via
The Motley Fool
Topics
Government
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
May 13, 2025
Via
The Motley Fool
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
May 13, 2025
Wall Street surges sharply as US-China tariff cuts drive tech stocks higher; pharma sector gains on new Trump drug pricing initiative.
Via
Chartmill
Topics
Government
World Trade
Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?
May 13, 2025
Eli Lilly trades at $759 per share and has stayed right on track with the overall market, losing 6.5% over the last six months while the S&P 500 is down 2.4%. This was partly driven by its softer...
Via
StockStory
Topics
Government
Stocks
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
May 12, 2025
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Via
Chartmill
Ford’s Cologne Workers To Strike On Wednesday, Says Report: Retail Sentiment Sours
May 12, 2025
According to a Reuters report, the strike comes in the wake of planned job cuts in the region.
Via
Stocktwits
Topics
Government
KindlyMD Stock Surges To All-Time High After Announcing Merger With Nakamoto To Launch Bitcoin Treasury Strategy
May 12, 2025
KindlyMD CEO Tim Pickett said the merger allows the company to preserve and expand its mission to combat opioid dependency through alternative medicine while gaining a new engine for shareholder value...
Via
Stocktwits
Topics
Government
Regulatory Compliance
Big News! U.S. and China Trade Deal Shakes Up Markets
May 12, 2025
Stocks are soaring today on the hope that the trade tensions between the U.S. and China are behind us.
Via
The Motley Fool
Topics
World Trade
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today